Home > National Drug Code (NDC) > Montelukast Sodium

Montelukast Sodium - 59762-0045-1 - (Montelukast Sodium)

Alphabetical Index


Drug Information of Montelukast Sodium

Product NDC: 59762-0045
Proprietary Name: Montelukast Sodium
Non Proprietary Name: Montelukast Sodium
Active Ingredient(s): 4    mg/1 & nbsp;   Montelukast Sodium
Administration Route(s): ORAL
Dosage Form(s): TABLET, CHEWABLE
Coding System: National Drug Codes(NDC)

Labeler Information of Montelukast Sodium

Product NDC: 59762-0045
Labeler Name: Greenstone LLC
Product Type: HUMAN PRESCRIPTION DRUG
FDA Application Number: ANDA202096
Marketing Category: ANDA
Start Marketing Date: 20120803

Package Information of Montelukast Sodium

Package NDC: 59762-0045-1
Package Description: 30 TABLET, CHEWABLE in 1 BOTTLE (59762-0045-1)

NDC Information of Montelukast Sodium

NDC Code 59762-0045-1
Proprietary Name Montelukast Sodium
Package Description 30 TABLET, CHEWABLE in 1 BOTTLE (59762-0045-1)
Product NDC 59762-0045
Product Type Name HUMAN PRESCRIPTION DRUG
Non Proprietary Name Montelukast Sodium
Dosage Form Name TABLET, CHEWABLE
Route Name ORAL
Start Marketing Date 20120803
Marketing Category Name ANDA
Labeler Name Greenstone LLC
Substance Name MONTELUKAST SODIUM
Strength Number 4
Strength Unit mg/1
Pharmaceutical Classes Leukotriene Receptor Antagonist [EPC],Leukotriene Receptor Antagonists [MoA]

Complete Information of Montelukast Sodium


General Information